Reports
Sale
Global Neurovascular Devices Market Size, Share, Growth, Trends, Forecast: By Product Type: Aneurysm Coiling and Embolization Devices, Cerebral Balloon Angioplasty and Stenting Systems, Support Devices, Neurothrombectomy Devices, Other Devices; By Disease; By End User; Regional Analysis; Supplier Landscape; 2024-2032
Global Neurovascular Devices Market Outlook
The global neurovascular devices market size reached a value of around USD 3.45 billion in 2023. The market is further expected to grow at a CAGR of 7.9% during the forecast period of 2024-2032, likely to attain a value of around USD 6.81 billion by 2032.
Neurovascular Devices: Introduction
Neurovascular devices are specially designed to be used in neurovascular disorders, such as brain aneurysm and stroke, among others. These medical devices are used for the diagnosis, treatment, and management of conditions that severely affect the blood vessels, especially in the central nervous system, particularly affecting the brain and the spinal cord. Neurovascular devices have both diagnostic and therapeutic uses.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Key Trends in the Neurovascular Devices Market
The growth of the neurovascular market is being driven by various factor, the primary factor being the rising prevalence of neurovascular disorders. Along with the rapidly growing geriatric population, factors like the rapidly developing healthcare infrastructure and rising investment on medical devices are also propelling the growth of the market. Various hospitals and healthcare organizations are increasingly adopting these devices due to the rising demand for the treatment of neurovascular disorders. Higher population is now affected with lifestyle disorders like high blood pressure and obesity, along with poor habits like smoking, which further deteriorate the health conditions. The rising investment and funding in research and development of better technology is also propelling the growth of the market.
Global Neurovascular Devices Market Analysis
Based on type, the market is divided into product type, disease, end user, and region.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Breakup by Product Type
- Aneurysm Coiling and Embolization Devices
- Cerebral Balloon Angioplasty and Stenting Systems
- Support Devices
- Neurothrombectomy Devices
- Other Devices
Market Breakup by Disease
- Ischemic Strokes
- Cerebral Aneurysms
- Arteriovenous Malformation and Fistulas
- Other Target Diseases
Market Breakup by End User
- Hospitals
- Clinics
- Home Healthcare
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Neurovascular Devices Market Scenario
The demand for neurovascular devices has been rapidly rising owing to the rising prevalence of neurovascular diseases triggered by unhealthy lifestyles and excessive stress. Among the regional markets, North America has been dominating the global market and is anticipated to lead the global market in the coming years as well. The dominance of the region can be attributed to the technological advancement in the healthcare sector in North America.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Europe and Asia Pacific are also likely to witness growth in the coming ears owing to the rapidly advancing healthcare sector and the increasing awareness about the neurovascular disorders and its available treatments.
Competitive Landscape
The comprehensive EMR report provides an in-depth assessment of the market based on Porter's five forces model, along with giving a SWOT analysis. The report gives a detailed analysis of the following key players in the global neurovascular devices market, covering their competitive landscape and the latest developments like mergers, acquisitions, investments, and expansion plans.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players.
- Johnson & Johnson
- Medtronic Plc
- Stryker Corporation
- Terumo Corporation
- ASAHI INTECC CO.
- Penumbra
- Acandis GmbH
- Braun Melsungen AG
- Integer Holdings Corporation
- Microport Scientific CorporatiON
- PHENOX GmbH
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product Type |
|
| Breakup by Disease |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Neurovascular Devices Market Overview
3.1 Global Neurovascular Devices Market Historical Value (2017-2023)
3.2 Global Neurovascular Devices Market Forecast Value (2024-2032)
4 Global Neurovascular Devices Market Landscape
4.1 Global Neurovascular Devices Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Neurovascular Devices Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Device Type
4.2.3 Analysis by End User
5 Global Neurovascular Devices Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Neurovascular Devices Market Segmentation
6.1 Global Neurovascular Devices Market by Product Type
6.1.1 Market Overview
6.1.2 Aneurysm Coiling and Embolization Devices
6.1.3 Cerebral Balloon Angioplasty and Stenting Systems
6.1.4 Support Devices
6.1.5 Neurothrombectomy Devices
6.1.6 Other Devices
6.2 Global Neurovascular Devices Market by Disease
6.2.1 Market Overview
6.2.2 Ischemic Strokes
6.2.3 Cerebral Aneurysms
6.2.4 Arteriovenous Malformation and Fistulas
6.2.5 Other Target Diseases
6.3 Global Neurovascular Devices Market by End User
6.3.1 Market Overview
6.3.2 Hospitals
6.3.3 Clinics
6.3.4 Home Healthcare
6.3.5 Others
6.4 Global Neurovascular Devices Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Neurovascular Devices Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Neurovascular Devices Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Neurovascular Devices Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Neurovascular Devices Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Neurovascular Devices Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding and Investment Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.2 US FDA
16.3 EU EMA
16.4 INDIA CDSCO
16.5 JAPAN PMDA
16.6 Others
17 Supplier Landscape
17.1 Johnson & Johnson
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Medtronic Plc
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Stryker Corporation
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Terumo Corporation
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 ASAHI INTECC CO.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Penumbra
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Acandis GmbH
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Braun Melsungen AG
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Integer Holdings Corporation
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Microport Scientific CorporatiON
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 PHENOX GmbH
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
18 Global Neurovascular Devices Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The market attained a value of USD 3.45 billion in 2023, driven by the rising cases of neurovascular diseases across the globe.
The market is anticipated to grow at a CAGR of 7.9% during the forecast period of 2024-2032 to attain a value of around USD 6.81 billion by 2032.
The growth of the market is driven by factors like rising awareness about the disease, the increasing availability of the treatment, and the rapid technological advancements.
The key trends which are bolstering the market growth include the rising investment and fundings by government and healthcare organizations.
The product types in the market include aneurysm coiling and embolization devices, cerebral balloon angioplasty and stenting systems, support devices, and neurothrombectomy devices, among other devices.
The diseases can be divided into ischemic strokes, cerebral aneurysms, arteriovenous malformation and fistulas, among other target diseases.
The end-users for the devices can be categorised into hospitals, clinics, and home healthcare, among others.
The major regional markets include North America, Europe, Asia Pacific, Latin America, Middle East and Africa.
The key players in the market can be categorised into Johnson & Johnson, Medtronic Plc, Stryker Corporation, Terumo Corporation, ASAHI INTECC CO., Penumbra, Acandis GmbH, Braun Melsungen AG, Integer Holdings Corporation, Microport Scientific CorporatiON, and PHENOX GmbH.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER